Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Daiichi Sankyo
Accenture
Fish and Richardson
Cantor Fitzgerald
Farmers Insurance
Chinese Patent Office
Moodys
Cerilliant
Baxter

Generated: December 11, 2017

DrugPatentWatch Database Preview

VISIPAQUE 270 Drug Profile

« Back to Dashboard

Which patents cover Visipaque 270, and what generic alternatives are available?

Visipaque 270 is a drug marketed by Ge Healthcare and is included in two NDAs.

The generic ingredient in VISIPAQUE 270 is iodixanol. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the iodixanol profile page.
Drug patent expirations by year for VISIPAQUE 270

Pharmacology for VISIPAQUE 270

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Ge HealthcareVISIPAQUE 270iodixanolINJECTABLE;INJECTION020351-001Mar 22, 1996RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Ge HealthcareVISIPAQUE 270iodixanolINJECTABLE;INJECTION020808-001Aug 29, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: VISIPAQUE 270

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ge HealthcareVISIPAQUE 270iodixanolINJECTABLE;INJECTION020808-001Aug 29, 1997► Subscribe► Subscribe
Ge HealthcareVISIPAQUE 270iodixanolINJECTABLE;INJECTION020351-001Mar 22, 1996► Subscribe► Subscribe
Ge HealthcareVISIPAQUE 270iodixanolINJECTABLE;INJECTION020808-001Aug 29, 1997► Subscribe► Subscribe
Ge HealthcareVISIPAQUE 270iodixanolINJECTABLE;INJECTION020808-001Aug 29, 1997► Subscribe► Subscribe
Ge HealthcareVISIPAQUE 270iodixanolINJECTABLE;INJECTION020808-001Aug 29, 1997► Subscribe► Subscribe
Ge HealthcareVISIPAQUE 270iodixanolINJECTABLE;INJECTION020351-001Mar 22, 1996► Subscribe► Subscribe
Ge HealthcareVISIPAQUE 270iodixanolINJECTABLE;INJECTION020808-001Aug 29, 1997► Subscribe► Subscribe
Ge HealthcareVISIPAQUE 270iodixanolINJECTABLE;INJECTION020351-001Mar 22, 1996► Subscribe► Subscribe
Ge HealthcareVISIPAQUE 270iodixanolINJECTABLE;INJECTION020351-001Mar 22, 1996► Subscribe► Subscribe
Ge HealthcareVISIPAQUE 270iodixanolINJECTABLE;INJECTION020351-001Mar 22, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Chubb
US Department of Justice
Fish and Richardson
Healthtrust
Argus Health
Farmers Insurance
Teva
Novartis
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot